nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—Propranolol—migraine	0.406	1	CrCtD
Bisoprolol—Bevantolol—Verapamil—migraine	0.0591	0.206	CrCrCtD
Bisoprolol—ADRB2—Timolol—migraine	0.0401	0.194	CbGbCtD
Bisoprolol—ADRB1—Timolol—migraine	0.0395	0.191	CbGbCtD
Bisoprolol—ADRB2—Propranolol—migraine	0.0357	0.173	CbGbCtD
Bisoprolol—ADRB1—Propranolol—migraine	0.0352	0.17	CbGbCtD
Bisoprolol—Betaxolol—Propranolol—migraine	0.0268	0.0932	CrCrCtD
Bisoprolol—Bevantolol—Propranolol—migraine	0.0268	0.0932	CrCrCtD
Bisoprolol—Acebutolol—Propranolol—migraine	0.0268	0.0932	CrCrCtD
Bisoprolol—Oxprenolol—Propranolol—migraine	0.0221	0.0768	CrCrCtD
Bisoprolol—Alprenolol—Propranolol—migraine	0.0221	0.0768	CrCrCtD
Bisoprolol—Metoprolol—Propranolol—migraine	0.0221	0.0768	CrCrCtD
Bisoprolol—Practolol—Propranolol—migraine	0.0221	0.0768	CrCrCtD
Bisoprolol—Atenolol—Propranolol—migraine	0.0209	0.0727	CrCrCtD
Bisoprolol—Esmolol—Propranolol—migraine	0.0198	0.069	CrCrCtD
Bisoprolol—Pindolol—Propranolol—migraine	0.0189	0.0658	CrCrCtD
Bisoprolol—CYP2D6—Timolol—migraine	0.0101	0.0487	CbGbCtD
Bisoprolol—CYP2D6—Propranolol—migraine	0.00896	0.0434	CbGbCtD
Bisoprolol—CYP2D6—Amitriptyline—migraine	0.00775	0.0375	CbGbCtD
Bisoprolol—CYP2D6—Verapamil—migraine	0.00615	0.0298	CbGbCtD
Bisoprolol—CYP3A4—Propranolol—migraine	0.0057	0.0276	CbGbCtD
Bisoprolol—CYP3A4—Amitriptyline—migraine	0.00493	0.0239	CbGbCtD
Bisoprolol—CYP3A4—Valproic Acid—migraine	0.00449	0.0218	CbGbCtD
Bisoprolol—CYP3A4—Topiramate—migraine	0.00405	0.0196	CbGbCtD
Bisoprolol—CYP3A4—Verapamil—migraine	0.00391	0.0189	CbGbCtD
Bisoprolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.000729	0.04	CbGpPWpGaD
Bisoprolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.000729	0.04	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000529	0.0291	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000518	0.0284	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000492	0.027	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.000481	0.0264	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000445	0.0244	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000435	0.0239	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000414	0.0227	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.000405	0.0222	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000321	0.0176	CbGpPWpGaD
Bisoprolol—Pindolol—HTR1B—migraine	0.000317	0.271	CrCbGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000314	0.0172	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000309	0.017	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000302	0.0166	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000298	0.0164	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000292	0.016	CbGpPWpGaD
Bisoprolol—Alprenolol—HTR1A—migraine	0.000291	0.249	CrCbGaD
Bisoprolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.00029	0.0159	CbGpPWpGaD
Bisoprolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000279	0.0153	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.00027	0.0148	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000264	0.0145	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000261	0.0143	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.00026	0.0143	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000256	0.014	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000254	0.0139	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000253	0.0139	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000253	0.0139	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000251	0.0138	CbGpPWpGaD
Bisoprolol—Pindolol—HTR1A—migraine	0.000251	0.215	CrCbGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000247	0.0136	CbGpPWpGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000247	0.0136	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000245	0.0135	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.00022	0.0121	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000215	0.0118	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000183	0.01	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000179	0.00983	CbGpPWpGaD
Bisoprolol—Propranolol—HTR1B—migraine	0.000173	0.148	CrCbGaD
Bisoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000165	0.00908	CbGpPWpGaD
Bisoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000162	0.00888	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000154	0.00844	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.00015	0.00826	CbGpPWpGaD
Bisoprolol—Propranolol—HTR1A—migraine	0.000137	0.117	CrCbGaD
Bisoprolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000126	0.00692	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Other—HTR7—migraine	0.000113	0.00623	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000105	0.00579	CbGpPWpGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000103	0.00567	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000102	0.00561	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	9.99e-05	0.00549	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	9.68e-05	0.00532	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.5e-05	0.00522	CbGpPWpGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	9.47e-05	0.0052	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.29e-05	0.0051	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—RAMP1—migraine	9.17e-05	0.00504	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—CALCRL—migraine	9.17e-05	0.00504	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	9.06e-05	0.00497	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—CALCRL—migraine	8.97e-05	0.00493	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—RAMP1—migraine	8.97e-05	0.00493	CbGpPWpGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	8.86e-05	0.00487	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	8.75e-05	0.00481	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	8.56e-05	0.0047	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.14e-05	0.00447	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	7.96e-05	0.00437	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Other—HTR2A—migraine	7.95e-05	0.00437	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR1D—migraine	6.67e-05	0.00366	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR1D—migraine	6.52e-05	0.00358	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2B—migraine	6.2e-05	0.0034	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.19e-05	0.0034	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2B—migraine	6.06e-05	0.00333	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.06e-05	0.00333	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	5.96e-05	0.00327	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	5.83e-05	0.0032	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.75e-05	0.00316	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.63e-05	0.00309	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.6e-05	0.00307	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.48e-05	0.00301	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.3e-05	0.00291	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.19e-05	0.00285	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	5.18e-05	0.00285	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	5.18e-05	0.00285	CbGpPWpGaD
Bisoprolol—Malaise—Valproic Acid—migraine	5.15e-05	0.000639	CcSEcCtD
Bisoprolol—Vertigo—Valproic Acid—migraine	5.13e-05	0.000636	CcSEcCtD
Bisoprolol—Asthenia—Propranolol—migraine	5.13e-05	0.000636	CcSEcCtD
Bisoprolol—Pneumonia—Topiramate—migraine	5.13e-05	0.000636	CcSEcCtD
Bisoprolol—Mental disorder—Timolol—migraine	5.12e-05	0.000634	CcSEcCtD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.11e-05	0.0028	CbGpPWpGaD
Bisoprolol—Erythema—Timolol—migraine	5.08e-05	0.00063	CcSEcCtD
Bisoprolol—Eye disorder—Gabapentin—migraine	5.08e-05	0.00063	CcSEcCtD
Bisoprolol—Depression—Topiramate—migraine	5.08e-05	0.00063	CcSEcCtD
Bisoprolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	5.07e-05	0.00279	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	5.07e-05	0.00279	CbGpPWpGaD
Bisoprolol—Tinnitus—Gabapentin—migraine	5.07e-05	0.000629	CcSEcCtD
Bisoprolol—Cardiac disorder—Gabapentin—migraine	5.05e-05	0.000626	CcSEcCtD
Bisoprolol—Palpitations—Valproic Acid—migraine	5.05e-05	0.000626	CcSEcCtD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.04e-05	0.00277	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.03e-05	0.00276	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.03e-05	0.00276	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	4.99e-05	0.00274	CbGpPWpGaD
Bisoprolol—Cough—Valproic Acid—migraine	4.98e-05	0.000618	CcSEcCtD
Bisoprolol—Dysgeusia—Timolol—migraine	4.98e-05	0.000617	CcSEcCtD
Bisoprolol—Urinary tract infection—Topiramate—migraine	4.95e-05	0.000614	CcSEcCtD
Bisoprolol—Conjunctivitis—Topiramate—migraine	4.95e-05	0.000614	CcSEcCtD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.93e-05	0.00271	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.93e-05	0.00271	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.92e-05	0.0027	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.92e-05	0.0027	CbGpPWpGaD
Bisoprolol—Mediastinal disorder—Gabapentin—migraine	4.9e-05	0.000608	CcSEcCtD
Bisoprolol—Diarrhoea—Propranolol—migraine	4.89e-05	0.000606	CcSEcCtD
Bisoprolol—Chest pain—Valproic Acid—migraine	4.86e-05	0.000603	CcSEcCtD
Bisoprolol—Myalgia—Valproic Acid—migraine	4.86e-05	0.000603	CcSEcCtD
Bisoprolol—Arthralgia—Valproic Acid—migraine	4.86e-05	0.000603	CcSEcCtD
Bisoprolol—Anxiety—Valproic Acid—migraine	4.84e-05	0.000601	CcSEcCtD
Bisoprolol—Hypersensitivity—Verapamil—migraine	4.84e-05	0.0006	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	4.83e-05	0.000599	CcSEcCtD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.82e-05	0.00265	CbGpPWpGaD
Bisoprolol—Alopecia—Gabapentin—migraine	4.8e-05	0.000596	CcSEcCtD
Bisoprolol—Discomfort—Valproic Acid—migraine	4.8e-05	0.000596	CcSEcCtD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.8e-05	0.00263	CbGpPWpGaD
Bisoprolol—Sinusitis—Topiramate—migraine	4.78e-05	0.000593	CcSEcCtD
Bisoprolol—Mental disorder—Gabapentin—migraine	4.76e-05	0.000591	CcSEcCtD
Bisoprolol—Agranulocytosis—Topiramate—migraine	4.76e-05	0.00059	CcSEcCtD
Bisoprolol—Dry mouth—Valproic Acid—migraine	4.75e-05	0.00059	CcSEcCtD
Bisoprolol—Erythema—Gabapentin—migraine	4.73e-05	0.000587	CcSEcCtD
Bisoprolol—Dizziness—Propranolol—migraine	4.72e-05	0.000586	CcSEcCtD
Bisoprolol—Asthenia—Verapamil—migraine	4.72e-05	0.000585	CcSEcCtD
Bisoprolol—ADRB1—Signaling by GPCR—CALCRL—migraine	4.71e-05	0.00259	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—RAMP1—migraine	4.71e-05	0.00259	CbGpPWpGaD
Bisoprolol—Confusional state—Valproic Acid—migraine	4.7e-05	0.000583	CcSEcCtD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.69e-05	0.00258	CbGpPWpGaD
Bisoprolol—Oedema—Valproic Acid—migraine	4.66e-05	0.000578	CcSEcCtD
Bisoprolol—Bradycardia—Topiramate—migraine	4.66e-05	0.000578	CcSEcCtD
Bisoprolol—Pruritus—Verapamil—migraine	4.65e-05	0.000577	CcSEcCtD
Bisoprolol—Angioedema—Timolol—migraine	4.64e-05	0.000576	CcSEcCtD
Bisoprolol—Dysgeusia—Gabapentin—migraine	4.64e-05	0.000575	CcSEcCtD
Bisoprolol—Infection—Valproic Acid—migraine	4.63e-05	0.000574	CcSEcCtD
Bisoprolol—ADRB2—Signaling by GPCR—RAMP1—migraine	4.61e-05	0.00253	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CALCRL—migraine	4.61e-05	0.00253	CbGpPWpGaD
Bisoprolol—Rhinitis—Topiramate—migraine	4.59e-05	0.000569	CcSEcCtD
Bisoprolol—Back pain—Gabapentin—migraine	4.58e-05	0.000568	CcSEcCtD
Bisoprolol—Hepatitis—Topiramate—migraine	4.57e-05	0.000567	CcSEcCtD
Bisoprolol—Nervous system disorder—Valproic Acid—migraine	4.57e-05	0.000567	CcSEcCtD
Bisoprolol—Vertigo—Timolol—migraine	4.57e-05	0.000566	CcSEcCtD
Bisoprolol—Thrombocytopenia—Valproic Acid—migraine	4.56e-05	0.000566	CcSEcCtD
Bisoprolol—Syncope—Timolol—migraine	4.56e-05	0.000565	CcSEcCtD
Bisoprolol—Hypoaesthesia—Topiramate—migraine	4.55e-05	0.000564	CcSEcCtD
Bisoprolol—Hallucination—Topiramate—migraine	4.55e-05	0.000564	CcSEcCtD
Bisoprolol—Muscle spasms—Gabapentin—migraine	4.55e-05	0.000564	CcSEcCtD
Bisoprolol—Tachycardia—Valproic Acid—migraine	4.55e-05	0.000564	CcSEcCtD
Bisoprolol—Vomiting—Propranolol—migraine	4.54e-05	0.000563	CcSEcCtD
Bisoprolol—Pharyngitis—Topiramate—migraine	4.54e-05	0.000563	CcSEcCtD
Bisoprolol—Skin disorder—Valproic Acid—migraine	4.53e-05	0.000561	CcSEcCtD
Bisoprolol—Oedema peripheral—Topiramate—migraine	4.51e-05	0.000559	CcSEcCtD
Bisoprolol—Hyperhidrosis—Valproic Acid—migraine	4.5e-05	0.000559	CcSEcCtD
Bisoprolol—Rash—Propranolol—migraine	4.5e-05	0.000559	CcSEcCtD
Bisoprolol—Dermatitis—Propranolol—migraine	4.5e-05	0.000558	CcSEcCtD
Bisoprolol—Diarrhoea—Verapamil—migraine	4.5e-05	0.000558	CcSEcCtD
Bisoprolol—Connective tissue disorder—Topiramate—migraine	4.5e-05	0.000557	CcSEcCtD
Bisoprolol—Palpitations—Timolol—migraine	4.49e-05	0.000557	CcSEcCtD
Bisoprolol—Loss of consciousness—Timolol—migraine	4.47e-05	0.000554	CcSEcCtD
Bisoprolol—Cough—Timolol—migraine	4.44e-05	0.00055	CcSEcCtD
Bisoprolol—Tremor—Gabapentin—migraine	4.43e-05	0.00055	CcSEcCtD
Bisoprolol—Visual impairment—Topiramate—migraine	4.41e-05	0.000547	CcSEcCtD
Bisoprolol—Ill-defined disorder—Gabapentin—migraine	4.39e-05	0.000545	CcSEcCtD
Bisoprolol—Hypotension—Valproic Acid—migraine	4.35e-05	0.00054	CcSEcCtD
Bisoprolol—Agitation—Gabapentin—migraine	4.35e-05	0.000539	CcSEcCtD
Bisoprolol—Dizziness—Verapamil—migraine	4.35e-05	0.000539	CcSEcCtD
Bisoprolol—Chest pain—Timolol—migraine	4.33e-05	0.000537	CcSEcCtD
Bisoprolol—Arthralgia—Timolol—migraine	4.33e-05	0.000537	CcSEcCtD
Bisoprolol—Myalgia—Timolol—migraine	4.33e-05	0.000537	CcSEcCtD
Bisoprolol—Angioedema—Gabapentin—migraine	4.32e-05	0.000536	CcSEcCtD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.32e-05	0.00237	CbGpPWpGaD
Bisoprolol—Anxiety—Timolol—migraine	4.31e-05	0.000535	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	4.3e-05	0.000533	CcSEcCtD
Bisoprolol—Discomfort—Timolol—migraine	4.28e-05	0.00053	CcSEcCtD
Bisoprolol—Eye disorder—Topiramate—migraine	4.27e-05	0.00053	CcSEcCtD
Bisoprolol—Malaise—Gabapentin—migraine	4.27e-05	0.000529	CcSEcCtD
Bisoprolol—Tinnitus—Topiramate—migraine	4.26e-05	0.000529	CcSEcCtD
Bisoprolol—Vertigo—Gabapentin—migraine	4.25e-05	0.000527	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Valproic Acid—migraine	4.25e-05	0.000526	CcSEcCtD
Bisoprolol—Cardiac disorder—Topiramate—migraine	4.25e-05	0.000526	CcSEcCtD
Bisoprolol—Flushing—Topiramate—migraine	4.25e-05	0.000526	CcSEcCtD
Bisoprolol—Syncope—Gabapentin—migraine	4.24e-05	0.000526	CcSEcCtD
Bisoprolol—Nausea—Propranolol—migraine	4.24e-05	0.000526	CcSEcCtD
Bisoprolol—Dry mouth—Timolol—migraine	4.23e-05	0.000525	CcSEcCtD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.22e-05	0.00232	CbGpPWpGaD
Bisoprolol—Insomnia—Valproic Acid—migraine	4.21e-05	0.000523	CcSEcCtD
Bisoprolol—Paraesthesia—Valproic Acid—migraine	4.18e-05	0.000519	CcSEcCtD
Bisoprolol—Palpitations—Gabapentin—migraine	4.18e-05	0.000519	CcSEcCtD
Bisoprolol—Confusional state—Timolol—migraine	4.18e-05	0.000519	CcSEcCtD
Bisoprolol—Vomiting—Verapamil—migraine	4.18e-05	0.000518	CcSEcCtD
Bisoprolol—Loss of consciousness—Gabapentin—migraine	4.16e-05	0.000516	CcSEcCtD
Bisoprolol—Dyspnoea—Valproic Acid—migraine	4.15e-05	0.000515	CcSEcCtD
Bisoprolol—Angiopathy—Topiramate—migraine	4.15e-05	0.000515	CcSEcCtD
Bisoprolol—Oedema—Timolol—migraine	4.15e-05	0.000514	CcSEcCtD
Bisoprolol—Rash—Verapamil—migraine	4.14e-05	0.000514	CcSEcCtD
Bisoprolol—Somnolence—Valproic Acid—migraine	4.14e-05	0.000514	CcSEcCtD
Bisoprolol—Dermatitis—Verapamil—migraine	4.14e-05	0.000513	CcSEcCtD
Bisoprolol—Cough—Gabapentin—migraine	4.13e-05	0.000512	CcSEcCtD
Bisoprolol—Mediastinal disorder—Topiramate—migraine	4.12e-05	0.000511	CcSEcCtD
Bisoprolol—Infection—Timolol—migraine	4.12e-05	0.000511	CcSEcCtD
Bisoprolol—Headache—Verapamil—migraine	4.12e-05	0.000511	CcSEcCtD
Bisoprolol—Dyspepsia—Valproic Acid—migraine	4.1e-05	0.000509	CcSEcCtD
Bisoprolol—Shock—Timolol—migraine	4.08e-05	0.000506	CcSEcCtD
Bisoprolol—Nervous system disorder—Timolol—migraine	4.07e-05	0.000504	CcSEcCtD
Bisoprolol—Alopecia—Topiramate—migraine	4.04e-05	0.000501	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—HTR1B—migraine	4.04e-05	0.00222	CbGpPWpGaD
Bisoprolol—Arthralgia—Gabapentin—migraine	4.03e-05	0.0005	CcSEcCtD
Bisoprolol—Chest pain—Gabapentin—migraine	4.03e-05	0.0005	CcSEcCtD
Bisoprolol—Myalgia—Gabapentin—migraine	4.03e-05	0.0005	CcSEcCtD
Bisoprolol—Skin disorder—Timolol—migraine	4.03e-05	0.0005	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Valproic Acid—migraine	4.02e-05	0.000499	CcSEcCtD
Bisoprolol—Fatigue—Valproic Acid—migraine	4.02e-05	0.000498	CcSEcCtD
Bisoprolol—Anxiety—Gabapentin—migraine	4.02e-05	0.000498	CcSEcCtD
Bisoprolol—Hyperhidrosis—Timolol—migraine	4.01e-05	0.000497	CcSEcCtD
Bisoprolol—Mental disorder—Topiramate—migraine	4.01e-05	0.000497	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	4e-05	0.000496	CcSEcCtD
Bisoprolol—Constipation—Valproic Acid—migraine	3.98e-05	0.000494	CcSEcCtD
Bisoprolol—Pain—Valproic Acid—migraine	3.98e-05	0.000494	CcSEcCtD
Bisoprolol—Erythema—Topiramate—migraine	3.98e-05	0.000494	CcSEcCtD
Bisoprolol—Discomfort—Gabapentin—migraine	3.98e-05	0.000494	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—HTR1B—migraine	3.95e-05	0.00217	CbGpPWpGaD
Bisoprolol—Dry mouth—Gabapentin—migraine	3.94e-05	0.000489	CcSEcCtD
Bisoprolol—Nausea—Verapamil—migraine	3.9e-05	0.000484	CcSEcCtD
Bisoprolol—Dysgeusia—Topiramate—migraine	3.9e-05	0.000484	CcSEcCtD
Bisoprolol—Confusional state—Gabapentin—migraine	3.89e-05	0.000483	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—HTR1A—migraine	3.89e-05	0.00213	CbGpPWpGaD
Bisoprolol—Hypotension—Timolol—migraine	3.88e-05	0.000481	CcSEcCtD
Bisoprolol—Oedema—Gabapentin—migraine	3.86e-05	0.000479	CcSEcCtD
Bisoprolol—Back pain—Topiramate—migraine	3.85e-05	0.000478	CcSEcCtD
Bisoprolol—Feeling abnormal—Valproic Acid—migraine	3.84e-05	0.000476	CcSEcCtD
Bisoprolol—Infection—Gabapentin—migraine	3.84e-05	0.000476	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—TAC1—migraine	3.83e-05	0.0021	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—NPS—migraine	3.83e-05	0.0021	CbGpPWpGaD
Bisoprolol—Muscle spasms—Topiramate—migraine	3.83e-05	0.000475	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Valproic Acid—migraine	3.81e-05	0.000473	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—HTR1A—migraine	3.8e-05	0.00209	CbGpPWpGaD
Bisoprolol—Shock—Gabapentin—migraine	3.8e-05	0.000471	CcSEcCtD
Bisoprolol—Nervous system disorder—Gabapentin—migraine	3.79e-05	0.00047	CcSEcCtD
Bisoprolol—Thrombocytopenia—Gabapentin—migraine	3.78e-05	0.000469	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Timolol—migraine	3.78e-05	0.000469	CcSEcCtD
Bisoprolol—Tachycardia—Gabapentin—migraine	3.77e-05	0.000468	CcSEcCtD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	3.77e-05	0.00207	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2C—migraine	3.75e-05	0.00206	CbGpPWpGaD
Bisoprolol—Skin disorder—Gabapentin—migraine	3.75e-05	0.000465	CcSEcCtD
Bisoprolol—Insomnia—Timolol—migraine	3.75e-05	0.000465	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—TAC1—migraine	3.75e-05	0.00206	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—NPS—migraine	3.75e-05	0.00206	CbGpPWpGaD
Bisoprolol—Hyperhidrosis—Gabapentin—migraine	3.73e-05	0.000463	CcSEcCtD
Bisoprolol—Tremor—Topiramate—migraine	3.73e-05	0.000463	CcSEcCtD
Bisoprolol—Paraesthesia—Timolol—migraine	3.72e-05	0.000462	CcSEcCtD
Bisoprolol—Urticaria—Valproic Acid—migraine	3.7e-05	0.000459	CcSEcCtD
Bisoprolol—Dyspnoea—Timolol—migraine	3.7e-05	0.000459	CcSEcCtD
Bisoprolol—Ill-defined disorder—Topiramate—migraine	3.69e-05	0.000458	CcSEcCtD
Bisoprolol—Somnolence—Timolol—migraine	3.69e-05	0.000457	CcSEcCtD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	3.69e-05	0.00202	CbGpPWpGaD
Bisoprolol—Body temperature increased—Valproic Acid—migraine	3.68e-05	0.000457	CcSEcCtD
Bisoprolol—Abdominal pain—Valproic Acid—migraine	3.68e-05	0.000457	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2C—migraine	3.67e-05	0.00202	CbGpPWpGaD
Bisoprolol—Agitation—Topiramate—migraine	3.66e-05	0.000454	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—EDNRA—migraine	3.65e-05	0.00201	CbGpPWpGaD
Bisoprolol—Dyspepsia—Timolol—migraine	3.65e-05	0.000453	CcSEcCtD
Bisoprolol—Hypotension—Gabapentin—migraine	3.61e-05	0.000448	CcSEcCtD
Bisoprolol—Malaise—Topiramate—migraine	3.59e-05	0.000445	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Timolol—migraine	3.58e-05	0.000444	CcSEcCtD
Bisoprolol—Vertigo—Topiramate—migraine	3.58e-05	0.000444	CcSEcCtD
Bisoprolol—Fatigue—Timolol—migraine	3.58e-05	0.000444	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—EDNRA—migraine	3.57e-05	0.00196	CbGpPWpGaD
Bisoprolol—Syncope—Topiramate—migraine	3.57e-05	0.000443	CcSEcCtD
Bisoprolol—Pain—Timolol—migraine	3.55e-05	0.00044	CcSEcCtD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.53e-05	0.00194	CbGpPWpGaD
Bisoprolol—Musculoskeletal discomfort—Gabapentin—migraine	3.52e-05	0.000436	CcSEcCtD
Bisoprolol—Palpitations—Topiramate—migraine	3.52e-05	0.000436	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—CALCA—migraine	3.52e-05	0.00193	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	3.5e-05	0.00192	CbGpPWpGaD
Bisoprolol—Loss of consciousness—Topiramate—migraine	3.5e-05	0.000434	CcSEcCtD
Bisoprolol—Insomnia—Gabapentin—migraine	3.49e-05	0.000433	CcSEcCtD
Bisoprolol—Cough—Topiramate—migraine	3.47e-05	0.000431	CcSEcCtD
Bisoprolol—Paraesthesia—Gabapentin—migraine	3.47e-05	0.00043	CcSEcCtD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.45e-05	0.0019	CbGpPWpGaD
Bisoprolol—Dyspnoea—Gabapentin—migraine	3.44e-05	0.000427	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—CALCA—migraine	3.44e-05	0.00189	CbGpPWpGaD
Bisoprolol—Somnolence—Gabapentin—migraine	3.43e-05	0.000426	CcSEcCtD
Bisoprolol—Hypersensitivity—Valproic Acid—migraine	3.43e-05	0.000426	CcSEcCtD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	3.43e-05	0.00188	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR1D—migraine	3.42e-05	0.00188	CbGpPWpGaD
Bisoprolol—Feeling abnormal—Timolol—migraine	3.42e-05	0.000424	CcSEcCtD
Bisoprolol—Dyspepsia—Gabapentin—migraine	3.4e-05	0.000422	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Timolol—migraine	3.39e-05	0.000421	CcSEcCtD
Bisoprolol—Arthralgia—Topiramate—migraine	3.39e-05	0.00042	CcSEcCtD
Bisoprolol—Chest pain—Topiramate—migraine	3.39e-05	0.00042	CcSEcCtD
Bisoprolol—Myalgia—Topiramate—migraine	3.39e-05	0.00042	CcSEcCtD
Bisoprolol—Anxiety—Topiramate—migraine	3.38e-05	0.000419	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	3.37e-05	0.000418	CcSEcCtD
Bisoprolol—Discomfort—Topiramate—migraine	3.35e-05	0.000415	CcSEcCtD
Bisoprolol—ADRB2—Signaling by GPCR—HTR1D—migraine	3.35e-05	0.00184	CbGpPWpGaD
Bisoprolol—Asthenia—Valproic Acid—migraine	3.34e-05	0.000415	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Gabapentin—migraine	3.33e-05	0.000414	CcSEcCtD
Bisoprolol—Fatigue—Gabapentin—migraine	3.33e-05	0.000413	CcSEcCtD
Bisoprolol—Dry mouth—Topiramate—migraine	3.32e-05	0.000411	CcSEcCtD
Bisoprolol—Pain—Gabapentin—migraine	3.3e-05	0.00041	CcSEcCtD
Bisoprolol—Constipation—Gabapentin—migraine	3.3e-05	0.00041	CcSEcCtD
Bisoprolol—Pruritus—Valproic Acid—migraine	3.3e-05	0.000409	CcSEcCtD
Bisoprolol—Urticaria—Timolol—migraine	3.3e-05	0.000409	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—HTR7—migraine	3.29e-05	0.00181	CbGpPWpGaD
Bisoprolol—Abdominal pain—Timolol—migraine	3.28e-05	0.000407	CcSEcCtD
Bisoprolol—Body temperature increased—Timolol—migraine	3.28e-05	0.000407	CcSEcCtD
Bisoprolol—Confusional state—Topiramate—migraine	3.28e-05	0.000406	CcSEcCtD
Bisoprolol—Oedema—Topiramate—migraine	3.25e-05	0.000403	CcSEcCtD
Bisoprolol—Infection—Topiramate—migraine	3.23e-05	0.0004	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—HTR7—migraine	3.22e-05	0.00177	CbGpPWpGaD
Bisoprolol—Shock—Topiramate—migraine	3.2e-05	0.000397	CcSEcCtD
Bisoprolol—Diarrhoea—Valproic Acid—migraine	3.19e-05	0.000395	CcSEcCtD
Bisoprolol—Nervous system disorder—Topiramate—migraine	3.19e-05	0.000395	CcSEcCtD
Bisoprolol—Feeling abnormal—Gabapentin—migraine	3.18e-05	0.000395	CcSEcCtD
Bisoprolol—Thrombocytopenia—Topiramate—migraine	3.18e-05	0.000395	CcSEcCtD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2B—migraine	3.18e-05	0.00175	CbGpPWpGaD
Bisoprolol—Tachycardia—Topiramate—migraine	3.17e-05	0.000393	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Gabapentin—migraine	3.16e-05	0.000392	CcSEcCtD
Bisoprolol—Skin disorder—Topiramate—migraine	3.16e-05	0.000391	CcSEcCtD
Bisoprolol—Hyperhidrosis—Topiramate—migraine	3.14e-05	0.00039	CcSEcCtD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2B—migraine	3.11e-05	0.00171	CbGpPWpGaD
Bisoprolol—Dizziness—Valproic Acid—migraine	3.08e-05	0.000382	CcSEcCtD
Bisoprolol—Urticaria—Gabapentin—migraine	3.07e-05	0.000381	CcSEcCtD
Bisoprolol—Hypersensitivity—Timolol—migraine	3.06e-05	0.000379	CcSEcCtD
Bisoprolol—Abdominal pain—Gabapentin—migraine	3.05e-05	0.000379	CcSEcCtD
Bisoprolol—Body temperature increased—Gabapentin—migraine	3.05e-05	0.000379	CcSEcCtD
Bisoprolol—Hypotension—Topiramate—migraine	3.04e-05	0.000377	CcSEcCtD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.02e-05	0.00166	CbGpPWpGaD
Bisoprolol—Asthenia—Timolol—migraine	2.98e-05	0.000369	CcSEcCtD
Bisoprolol—Vomiting—Valproic Acid—migraine	2.96e-05	0.000367	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Topiramate—migraine	2.96e-05	0.000367	CcSEcCtD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.96e-05	0.00162	CbGpPWpGaD
Bisoprolol—Insomnia—Topiramate—migraine	2.94e-05	0.000365	CcSEcCtD
Bisoprolol—Rash—Valproic Acid—migraine	2.94e-05	0.000364	CcSEcCtD
Bisoprolol—Dermatitis—Valproic Acid—migraine	2.94e-05	0.000364	CcSEcCtD
Bisoprolol—Pruritus—Timolol—migraine	2.93e-05	0.000364	CcSEcCtD
Bisoprolol—Headache—Valproic Acid—migraine	2.92e-05	0.000362	CcSEcCtD
Bisoprolol—Paraesthesia—Topiramate—migraine	2.92e-05	0.000362	CcSEcCtD
Bisoprolol—Dyspnoea—Topiramate—migraine	2.9e-05	0.000359	CcSEcCtD
Bisoprolol—Somnolence—Topiramate—migraine	2.89e-05	0.000358	CcSEcCtD
Bisoprolol—Dyspepsia—Topiramate—migraine	2.86e-05	0.000355	CcSEcCtD
Bisoprolol—Hypersensitivity—Gabapentin—migraine	2.85e-05	0.000353	CcSEcCtD
Bisoprolol—Diarrhoea—Timolol—migraine	2.84e-05	0.000352	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Topiramate—migraine	2.81e-05	0.000348	CcSEcCtD
Bisoprolol—Fatigue—Topiramate—migraine	2.8e-05	0.000347	CcSEcCtD
Bisoprolol—ADRB1—Signaling Pathways—RAMP1—migraine	2.78e-05	0.00153	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CALCRL—migraine	2.78e-05	0.00153	CbGpPWpGaD
Bisoprolol—Pain—Topiramate—migraine	2.78e-05	0.000345	CcSEcCtD
Bisoprolol—Constipation—Topiramate—migraine	2.78e-05	0.000345	CcSEcCtD
Bisoprolol—Asthenia—Gabapentin—migraine	2.77e-05	0.000344	CcSEcCtD
Bisoprolol—Nausea—Valproic Acid—migraine	2.77e-05	0.000343	CcSEcCtD
Bisoprolol—Dizziness—Timolol—migraine	2.74e-05	0.00034	CcSEcCtD
Bisoprolol—Pruritus—Gabapentin—migraine	2.73e-05	0.000339	CcSEcCtD
Bisoprolol—ADRB2—Signaling Pathways—CALCRL—migraine	2.72e-05	0.00149	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RAMP1—migraine	2.72e-05	0.00149	CbGpPWpGaD
Bisoprolol—Feeling abnormal—Topiramate—migraine	2.68e-05	0.000332	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Topiramate—migraine	2.66e-05	0.00033	CcSEcCtD
Bisoprolol—Diarrhoea—Gabapentin—migraine	2.64e-05	0.000328	CcSEcCtD
Bisoprolol—Vomiting—Timolol—migraine	2.64e-05	0.000327	CcSEcCtD
Bisoprolol—Rash—Timolol—migraine	2.62e-05	0.000324	CcSEcCtD
Bisoprolol—Dermatitis—Timolol—migraine	2.61e-05	0.000324	CcSEcCtD
Bisoprolol—Headache—Timolol—migraine	2.6e-05	0.000322	CcSEcCtD
Bisoprolol—Urticaria—Topiramate—migraine	2.58e-05	0.00032	CcSEcCtD
Bisoprolol—Abdominal pain—Topiramate—migraine	2.57e-05	0.000319	CcSEcCtD
Bisoprolol—Body temperature increased—Topiramate—migraine	2.57e-05	0.000319	CcSEcCtD
Bisoprolol—Dizziness—Gabapentin—migraine	2.55e-05	0.000317	CcSEcCtD
Bisoprolol—Nausea—Timolol—migraine	2.46e-05	0.000306	CcSEcCtD
Bisoprolol—Vomiting—Gabapentin—migraine	2.46e-05	0.000305	CcSEcCtD
Bisoprolol—Rash—Gabapentin—migraine	2.44e-05	0.000302	CcSEcCtD
Bisoprolol—Dermatitis—Gabapentin—migraine	2.43e-05	0.000302	CcSEcCtD
Bisoprolol—Headache—Gabapentin—migraine	2.42e-05	0.0003	CcSEcCtD
Bisoprolol—Hypersensitivity—Topiramate—migraine	2.39e-05	0.000297	CcSEcCtD
Bisoprolol—Asthenia—Topiramate—migraine	2.33e-05	0.000289	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2A—migraine	2.3e-05	0.00126	CbGpPWpGaD
Bisoprolol—Pruritus—Topiramate—migraine	2.3e-05	0.000285	CcSEcCtD
Bisoprolol—Nausea—Gabapentin—migraine	2.29e-05	0.000285	CcSEcCtD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	2.28e-05	0.00125	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2A—migraine	2.25e-05	0.00124	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	2.23e-05	0.00123	CbGpPWpGaD
Bisoprolol—Diarrhoea—Topiramate—migraine	2.22e-05	0.000276	CcSEcCtD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	2.2e-05	0.00121	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—NPS—migraine	2.16e-05	0.00119	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—TAC1—migraine	2.16e-05	0.00119	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	2.15e-05	0.00118	CbGpPWpGaD
Bisoprolol—Dizziness—Topiramate—migraine	2.15e-05	0.000267	CcSEcCtD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	2.12e-05	0.00117	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—TAC1—migraine	2.12e-05	0.00116	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—NPS—migraine	2.12e-05	0.00116	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	2.08e-05	0.00114	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR1B—migraine	2.07e-05	0.00114	CbGpPWpGaD
Bisoprolol—Vomiting—Topiramate—migraine	2.07e-05	0.000256	CcSEcCtD
Bisoprolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	2.06e-05	0.00113	CbGpPWpGaD
Bisoprolol—Rash—Topiramate—migraine	2.05e-05	0.000254	CcSEcCtD
Bisoprolol—Dermatitis—Topiramate—migraine	2.05e-05	0.000254	CcSEcCtD
Bisoprolol—Headache—Topiramate—migraine	2.04e-05	0.000252	CcSEcCtD
Bisoprolol—ADRB2—Signaling by GPCR—HTR1B—migraine	2.03e-05	0.00111	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR1D—migraine	2.02e-05	0.00111	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	2.02e-05	0.00111	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR1A—migraine	2e-05	0.0011	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CALCA—migraine	1.99e-05	0.00109	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR1D—migraine	1.98e-05	0.00109	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—TAC1—migraine	1.96e-05	0.00108	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—NPS—migraine	1.96e-05	0.00108	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR1A—migraine	1.95e-05	0.00107	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CALCA—migraine	1.94e-05	0.00107	CbGpPWpGaD
Bisoprolol—Nausea—Topiramate—migraine	1.93e-05	0.000239	CcSEcCtD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2C—migraine	1.93e-05	0.00106	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—TAC1—migraine	1.92e-05	0.00106	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—NPS—migraine	1.92e-05	0.00106	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2C—migraine	1.88e-05	0.00104	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2B—migraine	1.88e-05	0.00103	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EDNRA—migraine	1.87e-05	0.00103	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR7—migraine	1.86e-05	0.00102	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2B—migraine	1.84e-05	0.00101	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EDNRA—migraine	1.83e-05	0.00101	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR7—migraine	1.82e-05	0.000998	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CALCA—migraine	1.8e-05	0.000991	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CALCA—migraine	1.76e-05	0.000969	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR7—migraine	1.69e-05	0.000927	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LRP1—migraine	1.65e-05	0.000908	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR7—migraine	1.65e-05	0.000907	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LRP1—migraine	1.62e-05	0.000889	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.3e-05	0.000715	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.27e-05	0.000699	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.27e-05	0.000697	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.24e-05	0.000682	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CACNA1A—migraine	1.23e-05	0.000678	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.22e-05	0.000672	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.2e-05	0.000658	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.18e-05	0.000649	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.18e-05	0.000647	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NPS—migraine	1.16e-05	0.000637	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TAC1—migraine	1.16e-05	0.000637	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PGR—migraine	1.16e-05	0.000637	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.16e-05	0.000635	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.15e-05	0.000633	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.14e-05	0.000625	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NPS—migraine	1.14e-05	0.000624	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PGR—migraine	1.14e-05	0.000624	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TAC1—migraine	1.14e-05	0.000624	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.11e-05	0.000611	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.11e-05	0.000608	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.08e-05	0.000595	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.08e-05	0.000593	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CALCA—migraine	1.07e-05	0.000585	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.06e-05	0.00058	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CALCA—migraine	1.04e-05	0.000573	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR7—migraine	9.97e-06	0.000547	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR7—migraine	9.75e-06	0.000536	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TGFBR2—migraine	8.59e-06	0.000471	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TGFBR2—migraine	8.4e-06	0.000461	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CACNA1A—migraine	8.07e-06	0.000443	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2A—migraine	6.98e-06	0.000383	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2A—migraine	6.83e-06	0.000375	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ESR1—migraine	6.2e-06	0.00034	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ESR1—migraine	6.06e-06	0.000333	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—migraine	4.09e-06	0.000224	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—migraine	2.67e-06	0.000147	CbGpPWpGaD
